Insulet Corp. (PODD)
140.04
+2.81
(+2.05%)
USD |
NASDAQ |
Nov 20, 10:35
Insulet Cash from Operations (Quarterly) : 123.40M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 123.40M |
| June 30, 2026 | 88.50M |
| March 31, 2026 | 113.80M |
| December 31, 2025 | 183.30M |
| September 30, 2025 | 125.70M |
| June 30, 2025 | 196.50M |
| March 31, 2025 | 63.80M |
| December 31, 2024 | 147.70M |
| September 30, 2024 | 98.50M |
| June 30, 2024 | 96.50M |
| March 31, 2024 | 87.60M |
| December 31, 2023 | 44.90M |
| September 30, 2023 | 56.00M |
| June 30, 2023 | 44.00M |
| March 31, 2023 | 0.50M |
| December 31, 2022 | 50.70M |
| September 30, 2022 | 56.70M |
| June 30, 2022 | 25.30M |
| March 31, 2022 | -13.70M |
| December 31, 2021 | -25.50M |
| September 30, 2021 | -25.80M |
| June 30, 2021 | 18.30M |
| March 31, 2021 | -35.10M |
| December 31, 2020 | -1.00M |
| September 30, 2020 | 62.20M |
| Date | Value |
|---|---|
| June 30, 2020 | 26.40M |
| March 31, 2020 | -3.60M |
| December 31, 2019 | 46.93M |
| September 30, 2019 | 31.19M |
| June 30, 2019 | 13.91M |
| March 31, 2019 | 6.367M |
| December 31, 2018 | 30.44M |
| September 30, 2018 | 15.86M |
| June 30, 2018 | -6.129M |
| March 31, 2018 | -4.266M |
| December 31, 2017 | 21.80M |
| September 30, 2017 | 23.28M |
| June 30, 2017 | 17.96M |
| March 31, 2017 | -21.84M |
| December 31, 2016 | 20.07M |
| September 30, 2016 | 2.677M |
| June 30, 2016 | 3.681M |
| March 31, 2016 | -10.52M |
| December 31, 2015 | -18.60M |
| September 30, 2015 | 8.746M |
| June 30, 2015 | 0.785M |
| March 31, 2015 | -3.488M |
| December 31, 2014 | 4.607M |
| September 30, 2014 | 4.822M |
| June 30, 2014 | 0.508M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.048B |
| Abbott Laboratories | 1.737B |
| TransMedics Group, Inc. | 36.00M |
| The Cooper Cos., Inc. | 341.70M |
| Stryker Corp. | 1.461B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -66.90M |
| Cash from Financing (Quarterly) | -6.00M |
| Free Cash Flow | 232.60M |
| Free Cash Flow Per Share (Quarterly) | 0.885 |
| Free Cash Flow to Equity (Quarterly) | 47.80M |
| Free Cash Flow to Firm (Quarterly) | 74.40M |
| Free Cash Flow Yield | 2.39% |